IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice

  • Bae, Ji-Young (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University) ;
  • Moon, Sun-Hwa (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University) ;
  • Choi, Jung-Ah (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University) ;
  • Park, Jong-Sug (National Academy of Agricultural Science) ;
  • Hahn, Bum-Soo (National Academy of Agricultural Science) ;
  • Kim, Ki-Yong (National Institute of Animal Science) ;
  • Kim, Byung-Han (National Veterinary Research & Quarantine Service) ;
  • Song, Jae-Young (National Veterinary Research & Quarantine Service) ;
  • Kwon, Dae-Hyuck (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University) ;
  • Lee, Suk-Chan (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University) ;
  • Kim, Jong-Bum (National Academy of Agricultural Science) ;
  • Yang, Joo-Sung (Department of Genetic Engineering, Faculty of Life Sciences and Technology, Sungkyunkwan University)
  • Received : 2009.11.19
  • Accepted : 2009.12.18
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Foot-and-mouth disease virus (FMDV) is a small single-stranded RNA virus which belongs to the family Picornaviridae, genus Apthovirus. It is a principal cause of FMD which is highly contagious in livestock. In a wild type virus infection, infected animals usually elicit antibodies against structural and non-structural protein of FMDV. A structural protein, VP1, is involved in neutralization of virus particle, and has both B and T cell epitopes. A RNA-dependent RNA polymerase, 3D, is highly conserved among other serotypes and strongly immunogenic, therefore, we selected VP1 and 3D as vaccine targets. VP1 and 3D genes were codon-optimized to enhance protein expression level and cloned into mammalian expression vector. To produce recombinant protein, VP1 and 3D genes were also cloned into pET vector. The VP1 and 3D DNA or proteins were co-immunized into 5 weeks old BALB/C mice. Antigen-specific serum antibody (Ab) responses were detected by Ab ELISA. Cellular immune response against VP1 and 3D was confirmed by ELISpot assay. The results showed that all DNA- and protein-immunized groups induced cellular immune responses, suggesting that both DNA and recombinant protein vaccine administration efficiently induced Ag-specific humoral and cellular immune responses.

Keywords

References

  1. Balamurugan V, Kumar RM, Suryanarayana VV: Past and present vaccine development strategies for the control of foot-and-mouth disease. Acta Virol 48;201-214, 2004
  2. Knowles NJ, Samuel AR, Davies PR, Midgley RJ, Valarcher JF: Pandemic strain of foot-and-mouth disease virus serotype O. Emerg Infect Dis 11;1887-1893, 2005 https://doi.org/10.3201/eid1112.050908
  3. Patil PK, Suryanarayana V, Bist P, Bayry J, Natarajan C: Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies. Vaccine 20;1163-1168, 2002 https://doi.org/10.1016/S0264-410X(01)00431-5
  4. Collen T, Dimarchi R, Doel TR: A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146;749-755, 1991
  5. Wang JH, Liang CM, Peng JM, Shieh JJ, Jong MH, Lin YL, Sieber M, Liang SM: Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus: Vaccine 21;3721-3729, 2003 https://doi.org/10.1016/S0264-410X(03)00363-3
  6. Sanz-Parra A, Sobrino F, Ley V: Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol 79:433-436, 1998 https://doi.org/10.1099/0022-1317-79-3-433
  7. Yang NS, Wang JH, Lin KF, Wang CY, Kim SA, Yang YL, Jong MH, Kuo TY, Lai SS, Cheng RH, Chan MT, Liang SM: Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J Gene Med 7;708-717, 2005 https://doi.org/10.1002/jgm.723
  8. Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodriguez F: DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24;3889-3899, 2006 https://doi.org/10.1016/j.vaccine.2006.02.028
  9. Collen T, Baron J, Childerstone A, Corteyn A, Doel TR, Flint M, Garcia-Valcarcel M, Parkhouse RM, Ryan MD: Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res 56;125-133, 1998 https://doi.org/10.1016/S0168-1702(98)00035-5
  10. Cedillo-Barron L, Foster-Cuevas M, Cook A, Gutierrez- Castaneda B, Kollnberger S, Lefevre F, Parkhouse RM: Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21;4261-4269, 2003 https://doi.org/10.1016/S0264-410X(03)00453-5
  11. Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF: In vivo gene transfer to skin and wound by microseeding. J Surg Res 78;85-91, 1998 https://doi.org/10.1006/jsre.1998.5325
  12. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, et al.: Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A 91;9519-9523, 1994 https://doi.org/10.1073/pnas.91.20.9519
  13. Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT: Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol 79;4838-4847, 2005 https://doi.org/10.1128/JVI.79.8.4838-4847.2005
  14. Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, Maguire H, Kudchodkar S, Ramanathan MP, Weiner DB: Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J Infect Dis 184;809-816, 2001 https://doi.org/10.1086/323395
  15. Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM: DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J Gene Med 8;1182-1191, 2006 https://doi.org/10.1002/jgm.941
  16. Park JH, Kim SJ, Oem JK, Lee KN, Kim YJ, Kye SJ, Park JY, Joo YS: Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. J Vet ScI 7;257-262, 2006 https://doi.org/10.4142/jvs.2006.7.3.257
  17. Cedillo-Barron L, Foster-Cuevas M, Belsham GJ, Lefevre F, Parkhouse RM: Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82;1713-1724, 2001 https://doi.org/10.1099/0022-1317-82-7-1713
  18. Zhang Q, Zhu MW, Yang YQ, Shao M, Zhang ZY, Lan HY, Yan WY, Wu JJ, Zheng ZX: A recombinant fusion protein and DNA vaccines against foot-and-mouth disease virus type Asia 1 infection in guinea pigs. Acta Virol 47;237-243, 2003
  19. van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ: Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 69;4511-4514, 1995
  20. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ: Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 72;4454-4457, 1998

Cited by

  1. Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs vol.76, pp.3, 2009, https://doi.org/10.1134/s0006297911030072
  2. Strategies for Combating and Eradicating Important Infectious Diseases of Animals with Particular Reference to India: Present and Future Perspectives vol.9, pp.2, 2009, https://doi.org/10.3923/ajava.2014.77.106
  3. Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines vol.57, pp.1, 2009, https://doi.org/10.1186/s40781-015-0042-8
  4. In silico site-directed mutagenesis of neutralizing mAb 4C4 and analysis of its interaction with G-H loop of VP1 to explore its therapeutic applications against FMD vol.37, pp.10, 2009, https://doi.org/10.1080/07391102.2018.1494631
  5. Better Understanding of Important Aspects Associated with Vaccines Development for Controlling Viral Diseases in Animals vol.15, pp.3, 2009, https://doi.org/10.3923/ijds.2020.114.122